| Outcome Measures: |
Primary: Urinary Protein/Creatinine Ratio in Patients With Type 1 or 2 Diabetes., Urinary protein/creatinine ratio (mg/g) =urine protein concentration (mg/dL)/ urine creatinine concentration (g/dL). Outcome measure is the ratio of Week 52 \[LOCF\] urine protein/creatinine ratio over baseline urine protein/creatinine ratio., Assessed at Week 52, Last observation carried forward (LOCF) | Secondary: Urinary Protein/Creatinine Ratio at Week 26., Urinary protein/creatinine ratio (mg/g) =urine protein concentration (mg/dL)/ urine creatinine concentration (g/dL). Outcome measure is the ratio of Week 26 urine protein/creatinine ratio over baseline urine protein/creatinine ratio., Assessed at Week 26|Urinary Albumin/Creatinine Ratio at Week 26, Urinary albumin/creatinine ratio (mg/g) =urine albumin concentration (mg/dL)/ urine creatinine concentration (g/dL). Outcome measure is the ratio of Week 26 urine albumin/creatinine ratio over baseline urine albumin/creatinine ratio., Assessed at Week 26|Urinary Albumin/Creatinine Ratio at Week 52 [LOCF], Urinary albumin/creatinine ratio (mg/g) =urine albumin concentration (mg/dL)/ urine creatinine concentration (g/dL). Outcome measure is the ratio of Week 52 \[LOCF\] urine albumin/creatinine ratio over baseline urine albumin/creatinine ratio., Assessed at Week 52 LOCF|Change From Baseline in Estimated Glomerular Filtration Rate (eGFR) at Week 26, Assessed at Baseline and Week 26|Change From Baseline in eGFR at Week 52 [LOCF], Assessed at Baseline and Week 52 [LOCF]|Correlation Coefficient Urinary Protein/Creatinine Ratio and Total Cholesterol [TC] Indicating the Relationship Between Renal Effects and Lipid Changes, Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52 (LOCF)., 52 weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Protein/Creatinine Ratio TC, Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52, Assessed at 52 Weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Protein/Creatinine Ratio and Low Density Lipoprotein Cholesterol [LDL-C], Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Protein/Creatinine Ratio and LDL-C, Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Protein/Creatinine Ratio and High Density Lipoprotein Cholesterol [HDL-C], Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Protein/Creatinine Ratio and HDL-C, Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Protein/Creatinine Ratio and Non-high Density Lipoprotein Cholesterol [nonHDL-C], Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Protein/Creatinine Ratio and nonHDL-C, Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Protein/Creatinine Ratio and Triglyceride [TG], Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Protein/Creatinine Ratio and TG, Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Protein/Creatinine Ratio and TC/HDL-C Ratio, Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Protein/Creatinine Ratio and TC/HDL-C Ratio, Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Protein/Creatinine Ratio and LDL-C/HDL-C Ratio, Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Protein/Creatinine Ratio and LDL-C/HDL-C Ratio, Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Protein/Creatinine Ratio and nonHDL-C/HDL-C Ratio, Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Protein/Creatinine Ratio and nonHDL-C/HDL-C Ratio, Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Protein/Creatinine Ratio and Apolipoprotein A-1 [ApoA-1], Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Protein/Creatinine Ratio and ApoA-1, Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Protein/Creatinine Ratio and Apolipoprotein B [ApoB], Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Protein/Creatinine Ratio and ApoB, Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Protein/Creatinine Ratio and ApoB/ApoA-1 Ratio, Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Protein/Creatinine Ratio and ApoB/ApoA-1 Ratio, Correlation of changes from baseline in urinary protein/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Albumin/Creatinine Ratio and TC, Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Albumin/Creatinine Ratio and TC, Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Albumin/Creatinine Ratio and LDL-C, Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Albumin/Creatinine Ratio and LDL-C, Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Albumin/Creatinine Ratio and HDL-C, Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Albumin/Creatinine Ratio and HDL-C, Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Albumin/Creatinine Ratio and nonHDL-C, Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Albumin/Creatinine Ratio and nonHDL-C, Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Albumin/Creatinine Ratio and TG, Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Albumin/Creatinine Ratio and TG, Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Albumin/Creatinine Ratio and TC/HDL-C Ratio, Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Albumin/Creatinine Ratio and TC/HDL-C Ratio, Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Albumin/Creatinine Ratio and LDL-C/HDL-C Ratio, Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Albumin/Creatinine Ratio and LDL-C/HDL-C Ratio, Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Albumin/Creatinine Ratio and nonHDL-C/HDL-C Ratio, Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Albumin/Creatinine Ratio and nonHDL-C/HDL-C Ratio, Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Albumin/Creatinine Ratio and ApoA-1, Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Albumin/Creatinine Ratio and ApoA-1, Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Albumin/Creatinine Ratio and ApoB, Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Albumin/Creatinine Ratio and ApoB, Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Albumin/Creatinine Ratio and ApoB/ApoA-1 Ratio, Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: Urinary Albumin/Creatinine Ratio and ApoB/ApoA-1 Ratio, Correlation of changes from baseline in urinary albumin/creatinine ratio with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: eGFR and TC, Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: eGFR and TC, Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: eGFR and LDL-C, Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: eGFR and LDL-C, Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: eGFR and HDL-C, Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: eGFR and HDL-C, Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 Weeks|Relationship Between Renal Effects and Lipid Changes: eGFR and nonHDL-C, Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: eGFR and nonHDL-C, Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 weeks|Relationship Between Renal Effects and Lipid Changes: eGFR and TG, Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: eGFR and TG, Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 weeks|Relationship Between Renal Effects and Lipid Changes: eGFR and TC/HDL-C Ratio, Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: eGFR and TC/HDL-C Ratio, Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 weeks|Relationship Between Renal Effects and Lipid Changes: eGFR and LDL-C/HDL-C Ratio, Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: eGFR and LDL-C/HDL-C Ratio, Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 weeks|Relationship Between Renal Effects and Lipid Changes: eGFR and nonHDL-C/HDL-C Ratio, Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: eGFR and nonHDL-C/HDL-C Ratio, Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 weeks|Relationship Between Renal Effects and Lipid Changes: eGFR and ApoA1, Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: eGFR and ApoA1, Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 weeks|Relationship Between Renal Effects and Lipid Changes: eGFR and ApoB, Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: eGFR and ApoB, Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 weeks|Relationship Between Renal Effects and Lipid Changes: eGFR and ApoB/ApoA-1 Ratio, Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 26., 26 weeks|Relationship Between Renal Effects and Lipid Changes: eGFR and ApoB/ApoA-1 Ratio, Correlation of changes from baseline in eGFR with percent change from baseline in lipids and lipoprotein concentrations at Week 52, 52 weeks
|
| Locations: |
Research Site, Avondale, Arizona, United States|Research Site, Phoenix, Arizona, United States|Research Site, Jonesboro, Arkansas, United States|Research Site, Pasadena, California, United States|Research Site, Riverside, California, United States|Research Site, Santa Ana, California, United States|Research Site, West Hills, California, United States|Research Site, Hollywood, Florida, United States|Research Site, Jacksonville, Florida, United States|Research Site, West Palm Beach, Florida, United States|Research Site, Augusta, Georgia, United States|Research Site, Topeka, Kansas, United States|Research Site, Springfield, Massachusetts, United States|Research Site, Detroit, Michigan, United States|Research Site, Columbia, Missouri, United States|Research Site, St. Louis, Missouri, United States|Research Site, Orchard Park, New York, United States|Research Site, Stony Brook, New York, United States|Research Site, Winston Salem, North Carolina, United States|Research Site, Cincinnati, Ohio, United States|Research Site, Kettering, Ohio, United States|Research Site, Pittsburg, Pennsylvania, United States|Research Site, Columbia, South Carolina, United States|Research Site, Dallas, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Lubbock, Texas, United States|Research Site, San Antonio, Texas, United States|Research Site, Ogden, Utah, United States|Research Site, Milwaukee, Wisconsin, United States|Research Site, Buenos Aires, Argentina|Reasearch Site, La Plata, Argentina|Research Site, Moron, Argentina|Research Site, Quilmes, Argentina|Research Site, Curitiba, Brazil|Research Site, Fortaleza, Brazil|Research Site, Goiania, Brazil|Research Site, Recife, Brazil|Research Site, Sao Paulo, Brazil|Research Site, Burgas, Bulgaria|Research Site, Gabrovo, Bulgaria|Research Site, Pleven, Bulgaria|Research Site, Plovdiv, Bulgaria|Research Site, Sofia, Bulgaria|Research Site, Varna, Bulgaria|Research Site, Veliko Tarnovo, Bulgaria|Research Site, Vancouver, British Columbia, Canada|Research Site, Courtice, Ontario, Canada|Research Site, North York, Ontario, Canada|Research Site, Oshawa, Ontario, Canada|Research Site, Ottawa, Ontario, Canada|Research Site, Richmond Hill, Ontario, Canada|Research Site, Scarborough, Ontario, Canada|Research Site, Thunder Bay, Ontario, Canada|Research Site, Greenfield Park, Quebec, Canada|Research Site, Montreal, Quebec, Canada|Research Site, Aalborg, Denmark|Research Site, Blegdamsvej 9, Denmark|Research Site, Farso, Denmark|Research Site, Gentofte, Denmark|Research Site, Hillerod, Denmark|Research Site, Hvidovre, Denmark|Research Site, Koge, Denmark|Research Site, Annonay, France|Research Site, Besançon, France|Research Site, Bondy, France|Research Site, Colmar, France|Research Site, Corbeil Essonnes, France|Research Site, Corsept, France|Research Site, Creil Cedex, France|Research Site, Grenoble Cedex, France|Research Site, La Chapelle Sur Erdre, France|Research Site, Nantes, France|Research Site, Paris, France|Research Site, Pessac, France|Research Site, Quimper, France|Research Site, Baja, Hungary|Research Site, Balatonfured, Hungary|Research site, Budapest, Hungary|Research Site, Debrecen, Hungary|Research Site, Gyor, Hungary|Research site, Gyula, Hungary|Research Site, Hodmeztvasarhely, Hungary|Research Site, Kecskemét, Hungary|Research Site, Keszthely, Hungary|Research Site, Miskolc, Hungary|Research Site, Mosonmagyarovar, Hungary|Research Site, Nyiregyhaza, Hungary|Research Site, Szolnok, Hungary|Research Site, Székesfehérvár, Hungary|Research Site, Tatabanya, Hungary|Research Site, Zalaegerszeg, Hungary|Research Site, Acireale, CT, Italy|Research Site, Firenze, FI, Italy|Research Site, Roma, RM, Italy|Research Site, Sottomarnia Di Chioggia, VE, Italy|Research Site, Bergamo, Italy|Research Site, Cagliari, Italy|Research Site, Milano, Italy|Research Site, San Giovanni Rotondo, Italy|Research Site, Sassari, Italy|Research Site, Treviglio, Italy|Research Site, Aguascalientes, Mexico|Research Site, Cauntla, Mexico|Research Site, Distrito Federal, Mexico|Research Site, Durango, Mexico|Research Site, Guadalajara, Mexico|Research Site, Saltillo, Mexico|Research Site, San Luis Potosi, Mexico|Research Site, Zapopan, Mexico|Research Site, Baia Mare, Romania|Research Site, Brasov, Romania|Research Site, Bucharest, Romania|Research Site, Craiova, Romania|Research Site, Lasi, Romania|Research Site, Targu Mures, Romania|Research Site, Timisoara, Romania
|
